Whilst the reviews undertaken in the last decade by the World Federation of Societies for Biological Psychiatry and the Anxiety Disorders Research Network within the European College of Neuropsychopharmacology Network Initiative concluded than no biomarker was yet sufficient as a diagnostic tool, the authors were at pains to point out that a wealth of research had been amassed that improved the understanding anxiety disorders and their aetiology.2,3
References:
- Abi-Dargham A, Moeller SJ, Ali F, et al. Candidate biomarkers in psychiatric disorders: state of the field. World Psychiatry 2023; 22 (2): 236–262.
- Bandelow B, Baldwin D, Abelli M, et al. Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: neuroimaging and genetics. World J Biol Psychiatry 2016; 17 (5): 321–365.
- Bandelow B, Baldwin D, Abelli M, et al. Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry 2017; 18 (3): 162–214.